Arbutus Biopharma Corp (NASDAQ: ABUS) Is Up 23.60% Year-To-Date, But There Is Speculation That It Will Rally
Arbutus Biopharma Corp (NASDAQ:ABUS) traded at $3.09 at close of the session on Monday, April 08, made a downward move of -0.96% on its previous